The “cognitive clock”: A novel indicator of brain health
暂无分享,去创建一个
K. Arfanakis | Denis A. Evans | P. Boyle | R. Wilson | T. Beck | K. Rajan | R. Dawe | Tianhao Wang | D. Bennett | J. Schneider | Lei Yu | J. Schneider | D. Bennett
[1] Alan J. Thomas,et al. Recalibrating the epigenetic clock: implications for assessing biological age in the human cortex , 2020, bioRxiv.
[2] D. Bennett,et al. Normative Cognitive Decline in Old Age , 2020, Annals of neurology.
[3] S. Leurgans,et al. Proportion of cognitive loss attributable to terminal decline , 2019, Neurology.
[4] J. Schneider,et al. Contribution of TDP and hippocampal sclerosis to hippocampal volume loss in older-old persons , 2019, Neurology.
[5] D. Bennett,et al. Healthcare and Financial Decision Making and Incident Adverse Cognitive Outcomes among Older Adults , 2019, Journal of the American Geriatrics Society.
[6] D. Bennett,et al. Scam Awareness Related to Incident Alzheimer Dementia and Mild Cognitive Impairment , 2019, Annals of Internal Medicine.
[7] David A Bennett,et al. Religious Orders Study and Rush Memory and Aging Project. , 2018, Journal of Alzheimer's disease : JAD.
[8] Stuart J. Ritchie,et al. Brain age predicts mortality , 2017, Molecular Psychiatry.
[9] Seyed Abolfazl Valizadeh,et al. Age prediction on the basis of brain anatomical measures , 2017, Human brain mapping.
[10] S. Leurgans,et al. Cerebral amyloid angiopathy and cognitive outcomes in community-based older persons , 2015, Neurology.
[11] J. Vaupel,et al. University of Southern Denmark DNA methylation age is associated with mortality in a longitudinal Danish twin study , 2015 .
[12] Jennifer Weuve,et al. Cognitive impairment 18 years before clinical diagnosis of Alzheimer disease dementia , 2015, Neurology.
[13] S. Leurgans,et al. Residual decline in cognition after adjustment for common neuropathologic conditions. , 2015, Neuropsychology.
[14] S. Horvath,et al. DNA methylation age of blood predicts all-cause mortality in later life , 2015, Genome Biology.
[15] S. Horvath. DNA methylation age of human tissues and cell types , 2013, Genome Biology.
[16] J. Schneider,et al. Much of late life cognitive decline is not due to common neurodegenerative pathologies , 2013, Annals of neurology.
[17] C. Jack,et al. Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers , 2013, The Lancet Neurology.
[18] T. Ideker,et al. Genome-wide methylation profiles reveal quantitative views of human aging rates. , 2013, Molecular cell.
[19] Bernadette A. Thomas,et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 , 2012, The Lancet.
[20] David A. Bennett,et al. Decision Rules Guiding the Clinical Diagnosis of Alzheimer’s Disease in Two Community-Based Cohort Studies Compared to Standard Practice in a Clinic-Based Cohort Study , 2006, Neuroepidemiology.
[21] J. Schneider,et al. Individual differences in rates of change in cognitive abilities of older persons. , 2002, Psychology and aging.
[22] Colin O. Wu,et al. Nonparametric Mixed Effects Models for Unequally Sampled Noisy Curves , 2001, Biometrics.
[23] R Brookmeyer,et al. Age-specific incidence rates of Alzheimer’s disease , 2000, Neurology.
[24] S. Folstein,et al. “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinician , 1975 .
[25] R Core Team,et al. R: A language and environment for statistical computing. , 2014 .
[26] A. Hofman,et al. Prevalence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. , 2000, Neurology.
[27] M Haupt,et al. [Clinical diagnosis of Alzheimer's disease]. , 1988, Deutsche medizinische Wochenschrift.